144 related articles for article (PubMed ID: 1955565)
1. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.
Nakamura M; Kuroki M; Kira J; Itoyama Y; Shiraki H; Kuroda N; Washitani Y; Nakano S; Nagafuchi S; Anzai K
J Neuroimmunol; 1991 Dec; 35(1-3):167-77. PubMed ID: 1955565
[TBL] [Abstract][Full Text] [Related]
2. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.
Kitze B; Usuku K; Izumo S; Nakamura M; Shiraki H; Ijichi S; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
J Neurol; 1996 May; 243(5):393-400. PubMed ID: 8741079
[TBL] [Abstract][Full Text] [Related]
3. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
Jacobson S; Reuben JS; Streilein RD; Palker TJ
J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
[TBL] [Abstract][Full Text] [Related]
4. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
[TBL] [Abstract][Full Text] [Related]
5. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
[TBL] [Abstract][Full Text] [Related]
6. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
7. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
[TBL] [Abstract][Full Text] [Related]
8. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
[TBL] [Abstract][Full Text] [Related]
9. Standardisation of Western blotting to detect HTLV-1 antibodies synthesised in the central nervous system of HAM/TSP patients.
Ribeiro LC; Gonçalves CC; Slater CM; Carvalho SM; Puccioni-Sohler M
Mem Inst Oswaldo Cruz; 2013 Sep; 108(6):730-4. PubMed ID: 24037195
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
[TBL] [Abstract][Full Text] [Related]
12. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.
Mita S; Sugimoto M; Nakamura M; Murakami T; Tokunaga M; Uyama E; Araki S
Am J Trop Med Hyg; 1993 Feb; 48(2):170-7. PubMed ID: 8447519
[TBL] [Abstract][Full Text] [Related]
13. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M
J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514
[TBL] [Abstract][Full Text] [Related]
14. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Enose-Akahata Y; Jacobson S
Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
[TBL] [Abstract][Full Text] [Related]
15. Specificity of intrathecal IgG synthesis for HTLV-1 core and envelope proteins in HAM/TSP.
Kitze B; Puccioni-Sohler M; Schäffner J; Rieckmann P; Weber T; Felgenhauer K; Bodemer W
Acta Neurol Scand; 1995 Sep; 92(3):213-7. PubMed ID: 7484074
[TBL] [Abstract][Full Text] [Related]
16. The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Suzuki J; Kira J; Baba E; Nakamura M; Koyanagi Y; Nakamura T; Kawano Y; Yamasaki K; Shirabe S; Hatano N; Hayashi K; Yamamoto N; Kobayashi T
J Infect Dis; 1996 May; 173(5):1115-22. PubMed ID: 8627062
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
Dekaban GA; King EE; Arp J; Palker TJ; Rice GP
Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
J Neurol Sci; 1996 Oct; 142(1-2):65-9. PubMed ID: 8902722
[TBL] [Abstract][Full Text] [Related]
19. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
20. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
